Skip to main content
Premium Trial:

Request an Annual Quote

Tecan, Pierce Collaborate on Drug Discovery Products

NEW YORK, May 17 (GenomeWeb News) - Tecan and Pierce Biotechnology said today that they have agreed to collaborate on the development and marketing of a series of high-throughput screening solutions incorporating fluorescence lifetime technology.


According to the companies, FLT is a spectroscopic technology used for drug screening.


The partnership will combine Tecan's ultra evolution detection platform for high-throughput FLT measurements and Pierce's high-throughput screening assay technology.


The companies said that they will share specific product information under their arrangement, and each will co-promote the other's technologies in sales and marketing literature.


Additional terms were not disclosed.


The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.